Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 6;17(1):2.
doi: 10.1186/s13722-021-00284-0.

Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial

Elizabeth R Stevens  1 , Lei Lei  2 , Charles M Cleland  2 , Mahathi Vojjala  2   3 , Omar El-Shahawy  2   3 , Kenneth I Berger  2 , Thomas R Kirchner  3 , Scott E Sherman  2
Affiliations

Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial

Elizabeth R Stevens et al. Addict Sci Clin Pract. .

Abstract

Background: Smoking cessation is the most effective means of slowing the decline of lung function associated with chronic obstructive pulmonary disease (COPD). While effective smoking cessation treatments are available, they are underutilized and nearly half of people with COPD continue to smoke. By addressing both nicotine and behavioral dependence, electronic cigarettes (EC) could help people with COPD reduce the harm of combustible cigarettes (CC) through reductions in number of Cigarettes per Day (CPD) or quitting CC completely. The purpose of this pilot study is to identify barriers and facilitators to the use of and assess the preliminary effectiveness of EC as a harm reduction strategy among people with COPD.

Methods: In an open-label two-arm randomized controlled trial pilot study, 60 patients identified as smokers with a COPD diagnosis via electronic health records from a large urban health center are randomized in a 1:1 ratio to either standard care [counseling + nicotine replacement therapy (NRT)] or counseling + EC. The NRT arm will receive nicotine patches and nicotine lozenges for 12 weeks. The EC arm will receive EC for 12 weeks. Both cohorts will receive counseling from a licensed mental health counselor. Using ecological momentary assessment, participants will report their use of CC in both arms and EC use in the EC arm daily via text message. Primary outcomes will be feasibility and acceptability of intervention, and secondary outcomes will be reduction in CPD and change in COPD symptoms as measured by COPD Assessment Tool (CAT) score at 12-weeks. EC displacement of CC. To explore attitudes towards the use of EC as a harm-reduction strategy for patients with COPD, interviews will be performed with a sample of participants from both study arms.

Discussion: Despite decades of availability of smoking cessation medications, nearly half of people with COPD still smoke. This study aims to address the unmet need for feasible and effective strategies for reducing CC use among those with COPD, which has the potential to significantly improve the health of people with COPD who smoke. Trial Registration ClinicalTrials.gov Identifier: NCT04465318.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
SPIRIT flow diagram: schedule of enrolment, interventions and assessments
Fig. 2
Fig. 2
Daily text message script
See this image and copyright information in PMC

References

    1. National Center for Chronic Disease P, Health Promotion Office on S, Health . Reports of the surgeon general. The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention (US); 2014. - PubMed
    1. Centers for Disease Control and Prevention. Tobacco-Related Mortality. 2014. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/t.... Accessed 1 Nov 2021.
    1. National Institutes of Health. COPD National Action Plan. 2017. https://www.nhlbi.nih.gov/health-topics/education-and-awareness/COPD-nat.... Accessed 1 Nov 2021.
    1. Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. - PMC - PubMed
    1. Altose MD. Approaches to slowing the progression of COPD. Curr Opin Pulm Med. 2003;9(2):125–130. - PubMed

Publication types

MeSH terms

Associated data